₹2,603.4
▲ +15.01 +0.58%
29 Jul 2026
NSE Listed · Pharmaceuticals
Caplin Point Laboratories Ltd. (CAPLIPOINT)
Volume: 39,117Avg Vol 1W: 1,28,225Avg Vol 1M: 1,27,02352W Range:₹1,500.3₹2,699
Key Ratios
Checked just nowMarket Cap₹19,789 Cr
Current Price₹2,603.4
Previous Close₹2,588.39
High / Low (52w)₹2,699 / ₹1,500.3
Volume39,117
Avg Vol (1W)1,28,225
Avg Vol (1M)1,27,023
Stock P/E116.33
Book Value₹471.9
Dividend Yield0.17%
ROE17.88%
ROA16.06%
Revenue (TTM)—
Revenue Growth14.37%
Profit Margin29.32%
Total Debt₹0 Cr
Shares Outstanding8 Cr
Face Value₹2
EPS (TTM)₹22.38
P/B5.52
Debt / Equity0
50 DMA₹2,382.76
200 DMA₹1,963.81
Day change+0.58%
Price Chart
₹2,603.4▲ 24.82% · 1Y
2025-07-292026-07-29
20-day avg volume: 1.2L shares
Pros
- Healthy return on equity of 17.9%.
- Company is almost debt-free.
- Net profit is growing year over year.
Cons
- Stock trades at a high P/E of 116.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹459 Cr | ₹483 Cr | ₹493 Cr | ₹502 Cr | ₹510 Cr | ₹534 Cr | ₹543 Cr | ₹600 Cr |
| EBITDA | ₹154 Cr | ₹169 Cr | ₹177 Cr | ₹177 Cr | ₹185 Cr | ₹201 Cr | ₹204 Cr | ₹214 Cr |
| Net Profit | ₹124 Cr | ₹131 Cr | ₹139 Cr | ₹143 Cr | ₹153 Cr | ₹154 Cr | ₹164 Cr | ₹170 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹208 Cr | ₹185 Cr | ₹174 Cr | ₹2,034 Cr | ₹183 Cr | ₹175 Cr | ₹189 Cr | ₹191 Cr |
| EBITDA | ₹135 Cr | ₹100 Cr | ₹110 Cr | ₹677 Cr | ₹113 Cr | ₹129 Cr | ₹117 Cr | ₹138 Cr |
| Net Profit | ₹106 Cr | ₹75 Cr | ₹87 Cr | ₹536 Cr | ₹86 Cr | ₹103 Cr | ₹87 Cr | ₹110 Cr |
| EPS | — | — | — | 70.25 | — | — | — | — |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹500 Cr | ₹743 Cr | ₹1,126 Cr | ₹1,364 Cr | ₹1,736 Cr | ₹2,191 Cr | ₹2,698 Cr | ₹3,208 Cr |
| Total Liabilities | ₹137 Cr | ₹110 Cr | ₹169 Cr | ₹160 Cr | ₹226 Cr | ₹284 Cr | ₹351 Cr | ₹321 Cr |
| Equity | ₹364 Cr | ₹633 Cr | ₹957 Cr | ₹1,203 Cr | ₹1,510 Cr | ₹1,907 Cr | ₹2,347 Cr | ₹2,886 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹103 Cr | ₹126 Cr | ₹99 Cr | ₹335 Cr | ₹418 Cr | ₹359 Cr | ₹427 Cr | ₹560 Cr |
| Investing | ₹-69 Cr | ₹-100 Cr | ₹-55 Cr | ₹-29 Cr | ₹-377 Cr | ₹-218 Cr | ₹-320 Cr | ₹-335 Cr |
| Financing | ₹-12 Cr | ₹90 Cr | ₹80 Cr | ₹-24 Cr | ₹-41 Cr | ₹-28 Cr | ₹-38 Cr | ₹-38 Cr |
| Free Cash Flow | ₹103 Cr | ₹126 Cr | ₹99 Cr | ₹335 Cr | ₹418 Cr | ₹359 Cr | ₹427 Cr | ₹560 Cr |
Shareholding
Promoter 70.57% Institutions 8.25% Public 21.18%
Efficiency & Working Capital
ROCE26%
Interest Coverage1110.5
Dividend Payout—
Debtor Days119 d
Inventory Days63 d
Payable Days41 d
Cash Conversion Cycle141 d
Working Capital Days182 d
Shareholding Details
As of 2026-06-30
Promoter70.6%
FII5.8%
DII2.5%
Institutions8.2%
Public21.2%
Promoter Pledge0%
No. of Shareholders94,385
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% |
| FIIs | 3.1% | 2.8% | 3.3% | 3.4% | 3.7% | 4.9% | 5.7% | 6.2% | 6.5% | 6.6% | 6.1% | 5.8% |
| DIIs | 0.2% | 0.4% | 1.1% | 1.5% | 1.8% | 2.1% | 2% | 2.2% | 2.1% | 2.1% | 2.1% | 2.5% |
| Public | 26.1% | 26.1% | 25% | 24.6% | 23.9% | 22.5% | 21.7% | 21.1% | 20.8% | 20.8% | 21.1% | 21.2% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 78,068 | 79,438 | 81,409 | 80,411 | 96,123 | 92,702 | 96,387 | 94,169 | 93,753 | 93,705 | 93,896 | 94,385 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| P Vijayalakshmi | Shareholding of Promoter and Promoter Group | 24.7% | 1.88 Cr |
| Paarthipan C C | Shareholding of Promoter and Promoter Group | 18.6% | 1.42 Cr |
| Ashok Gorkey Partheeban | Shareholding of Promoter and Promoter Group | 11.9% | 90,50,000 |
| Partheeban Vivek Siddarth | Shareholding of Promoter and Promoter Group | 11.9% | 90,09,371 |
| Investor Education And Protection Fund Authority Ministry Of Corporate Affairs | Public Shareholding | 2.9% | 21,78,485 |
| May India Property Private Limited | Shareholding of Promoter and Promoter Group | 2.8% | 21,17,000 |
| Uti Multi Cap Fund | Public Shareholding | 1.8% | 13,78,701 |
| Pinebridge Global Funds - Pinebridge India Equity Fund | Public Shareholding | 1.1% | 8,00,745 |
| First Dimension Holdings Private Limited | Shareholding of Promoter and Promoter Group | 0.5% | 3,70,000 |
| Kiraviz Properties And Consultancy Llp | Shareholding of Promoter and Promoter Group | 0.2% | 1,50,000 |
| Visalatchi P | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Chellappan Poovalambedu Kandasamy | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Kotteswari B | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Soundari B | Shareholding of Promoter and Promoter Group | 0% | 0 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| C C Paarthipan | Chairman & Non Executive Dir. | 2025 |
| Sridhar Ganesan | Non Independent Executive Director / MD | 2025 |
| R Vijayaraghavan | Independent Non Exe. Director | 2025 |
| C K Gariyali | Independent Non Exe. Director | 2025 |
| Deenadayalan Singaram | Independent Non Exe. Director | 2025 |
| R Nagendran | Independent Non Exe. Director | 2025 |
| VENKATRAM GANAPATHYSUBRAMANIAN | Co. Sec. / Comp. Officer / General Counsel | 2025 |
| K C John | Additional Director | 2025 |
| ASHOK GORKEY PARTHEEBAN | Vice Chairman & Additional Director | 2025 |
| PARTHEEBAN VIVEK SIDDARTH | Vice Chairman & Additional Director | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Manufacture of pharmaceuticals form | ₹0 Cr | — |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹2 | 17 | 15 | 15 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| dividend | 2026-05-29 | ₹4.0 (200.0%) | Interim |
| dividend | 2026-05-29 | ₹4 (200%) | Interim |
| dividend | 2025-09-12 | ₹3 (150%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 640 | 0 | 0 | 2 | 0 | 642 |
| 2025 | 246 | 0 | 0 | 0 | 0 | 246 |
| 2025 | 0 | 0 | 0 | 2 | 0 | 2 |
Insider / Designated-Person Trades
30 recent disclosure(s)
P VijayalakshmiAcquisition · 8,98,790
Sathish KrishnanDisposal · 5,000
Arulsudar NatrajanDisposal · 1,500
Arulsudar NatrajanDisposal · 2,000
Arulsudar NatrajanDisposal · 1,500
Subramanian NarayanaswamyDisposal · 100
Company Information
Incorporated1990
ChairmanC C Paarthipan
AuditorBrahmayya & Co
Investor Email[email protected]; [email protected]
📍 Ashvich Towers 3rd Floor, No 3 Developed Plots Ind Estat, Chennai, Tamil Nadu, 600096
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Canara HSBC Life Insurance Company Ltd.Cantabil Retail India Ltd.Capacite Infraproject Ltd.Capillary Technologies India Ltd.Capital Infra TrustCapital Small Fin Bank LimitedCapital Trust LimitedCarborundum Universal Ltd.CARE Ratings LimitedCarraro India LimitedCarTrade Tech LimitedCARYSIL LimitedAll “C” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search